|
Melanotan (other)
Melanotan may refer to one of two separate peptides: * Afamelanotide Afamelanotide, sold under the brand name Scenesse, is a medication used to prevent phototoxicity and to reduce pain from light exposure for people with erythropoietic protoporphyria. It is a melanocortin 1 receptor (MC1 receptor) agonist an ..., originally developed under the names "Melanotan", "Melanotan-1", or "Melanotan I" for skin tanning, a drug currently available for prescription for certain light related skin indications and also in trials in implant form as a prophylactic treatment for a series of light affected skin disorders and potential skin cancer preventative agent * Melanotan II, a drug originally developed as a skin tanning agent, but subsequently investigated as a potential treatment for sexual dysfunction {{set index article ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Afamelanotide
Afamelanotide, sold under the brand name Scenesse, is a medication used to prevent phototoxicity and to reduce pain from light exposure for people with erythropoietic protoporphyria. It is a melanocortin 1 receptor (MC1 receptor) agonist and a synthetic peptide and analogue of α-melanocyte stimulating hormone. It is administered as subcutaneous implant. The US Food and Drug Administration (FDA) considers it to be a first-in-class medication. Medical uses In the European Union, afamelanotide is indicated for the prevention of phototoxicity in adults with erythropoietic protoporphyria. In the United States, afamelanotide is indicated for increasing pain-free light exposure in adults with a history of reactions to light (phototoxicity) from erythropoietic protoporphyria. Adverse effects Very common adverse effects include nausea and headache (may affect more than 10% of people). Common adverse effects include injection site reactions, back pain, upper respiratory trac ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |